Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

Please sign in to follow a disease.

← Back to home

Danatlas Pharmaceuticals Co., Ltd

Clinical trials sponsored by Danatlas Pharmaceuticals Co., Ltd, explained in plain language.

Not yet recruiting 1

New pill shows promise for Hard-to-Treat ovarian cancer

Disease control Not yet recruiting

This study tests a new oral drug called DAT-2645 in up to 30 people with advanced or metastatic ovarian cancer that has a BRCA1/2 mutation or is HRD-positive. Participants take the drug daily in 21-day cycles. The main goal is to see if the drug shrinks tumors, and researchers wi…

Phase 2 • Sponsor: Danatlas Pharmaceuticals Co., Ltd • Aim: Disease control

Last updated Jun 27, 2026 14:02 UTC